Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
CTMX
CTMX News & Events
-
Add to Watchlist
Trade CTMX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
CTMX News
Birkenstock, Insmed, and Other Major Stocks Decline in Thursday's Pre-Market Trading
Dec 18 2025
Benzinga
Analysts Discuss the Evolving CytomX Narrative Following Recent Clinical Progress and Increased Price Target
Nov 22 2025
Yahoo Finance
HC Wainwright & Co. Reaffirms Buy Rating for CytomX Therapeutics and Increases Price Target to $10
Nov 11 2025
Benzinga
CytomX announces Q1 2026 data update for CX-2051 and achieves 100-patient enrollment milestone as Phase Ib study progresses.
Nov 07 2025
SeekingAlpha
CytomX Therapeutics Stock: An In-Depth Look at Analyst Opinions (4 Ratings)
Oct 21 2025
Benzinga
Barclays Keeps Overweight Rating on CytomX Therapeutics and Increases Price Target to $6
Oct 21 2025
Benzinga
Cantor Fitzgerald Begins Coverage of CytomX Therapeutics with Overweight Rating and Sets Price Target at $6
Sep 22 2025
Benzinga
Serina Therapeutics Stock Rises Over 25%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 26 2025
Benzinga
Show More News
CTMX Events
No data
CTMX Monitor News
No data
CTMX Earnings Analysis
No Data
People Also Watch
